UBS Capital Reform Legislative Progress: Parliamentary Committee Reviews Relaxation Plan This Week
0xBroomberg
Switzerland's upper-house economics committee meets Tuesday to review capital-rule reform proposals for UBS — several alternatives would dilute the government's original ~$20 billion extra-capital demand, setting the real boundary of UBS's future capital burden.
How much did the government want UBS to raise?
The finance ministry proposed that UBS cover the full book value of its foreign subsidiaries with Common Equity Tier 1 (CET1) — the most expensive, loss-absorbing form of bank capital.
This means → UBS would need roughly $20 billion in additional CET1, directly squeezing capacity for dividends and buybacks.
The proposal is the regulatory core response to Credit Suisse's collapse over three years ago. UBS called it "extreme" and warned it would harm competitiveness and the Swiss economy.
What relaxation options are on the table?
Option A: Cut the foreign-subsidiary CET1 coverage ratio from 100% to 80% or 75% — a straight discount on the bill.
Option B: Link the capital requirement to the actual size of UBS's overseas operations — shrink abroad, pay less.
Option C: Allow UBS to fill up to half the capital gap with AT1 bonds — a hybrid instrument sitting between equity and senior debt — rather than pure equity.
In plain terms = all three paths ask the same question: can the $20 billion bill be discounted, or met with cheaper instruments?
Why is the AT1 option the most contentious?
The AT1 proposal is backed by centre-right parties and Switzerland's largest party — it carries the strongest political momentum.
To broaden support, sponsors added safeguards: if UBS's capital ratio drops below a set threshold, coupon payments on AT1s and shareholder dividends are banned, and bonus payouts are forcibly deferred.
This means → the AT1's loss-absorption function is strengthened — a direct response to Credit Suisse's collapse, when AT1 holders were wiped out, exposing the instrument's fragility under stress.
But AT1 investors are cautious: larger issuance + tighter terms = diluted bondholder economics. UBS is already one of the world's largest AT1 issuers.
How long until this becomes law?
This week's committee review → recommendation to the upper house → upper-house vote likely during next month's autumn session → then to the lower house.
The lower house has a higher share of left-leaning members; UBS may face stiffer resistance. The full process is not expected to conclude before next year.
This reflects Switzerland's consensus-politics rhythm: even when direction is clear, formal legislation requires prolonged multi-round negotiation.
What does the current picture mean for UBS?
The committee's majority view remains unclear; if no consensus forms, the decision may be deferred to the August 31 session.
But one broad consensus already exists: capital requirements should be above current levels — the dispute is only over how much higher and which instruments qualify.
This means → the original proposal is more likely to be diluted than adopted intact, but a "no increase" outcome is essentially off the table. UBS's real capital pressure will land somewhere between $20 billion and the status quo.
Content is for reference only, not financial advice.